S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   180.97 (-0.85%)
MSFT   408.13 (-0.54%)
META   481.59 (-0.50%)
GOOGL   138.61 (-3.72%)
AMZN   174.88 (-0.06%)
TSLA   199.85 (+4.10%)
NVDA   797.91 (+1.24%)
NIO   5.58 (+3.33%)
AMD   176.57 (+0.03%)
BABA   76.15 (+0.25%)
T   16.66 (-0.83%)
F   12.13 (-0.08%)
MU   90.77 (+5.55%)
CGC   3.46 (+2.98%)
GE   154.64 (+0.85%)
DIS   108.63 (+0.83%)
AMC   4.48 (+0.90%)
PFE   27.23 (-1.91%)
PYPL   59.79 (+1.06%)
XOM   104.43 (+0.57%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   180.97 (-0.85%)
MSFT   408.13 (-0.54%)
META   481.59 (-0.50%)
GOOGL   138.61 (-3.72%)
AMZN   174.88 (-0.06%)
TSLA   199.85 (+4.10%)
NVDA   797.91 (+1.24%)
NIO   5.58 (+3.33%)
AMD   176.57 (+0.03%)
BABA   76.15 (+0.25%)
T   16.66 (-0.83%)
F   12.13 (-0.08%)
MU   90.77 (+5.55%)
CGC   3.46 (+2.98%)
GE   154.64 (+0.85%)
DIS   108.63 (+0.83%)
AMC   4.48 (+0.90%)
PFE   27.23 (-1.91%)
PYPL   59.79 (+1.06%)
XOM   104.43 (+0.57%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   180.97 (-0.85%)
MSFT   408.13 (-0.54%)
META   481.59 (-0.50%)
GOOGL   138.61 (-3.72%)
AMZN   174.88 (-0.06%)
TSLA   199.85 (+4.10%)
NVDA   797.91 (+1.24%)
NIO   5.58 (+3.33%)
AMD   176.57 (+0.03%)
BABA   76.15 (+0.25%)
T   16.66 (-0.83%)
F   12.13 (-0.08%)
MU   90.77 (+5.55%)
CGC   3.46 (+2.98%)
GE   154.64 (+0.85%)
DIS   108.63 (+0.83%)
AMC   4.48 (+0.90%)
PFE   27.23 (-1.91%)
PYPL   59.79 (+1.06%)
XOM   104.43 (+0.57%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   180.97 (-0.85%)
MSFT   408.13 (-0.54%)
META   481.59 (-0.50%)
GOOGL   138.61 (-3.72%)
AMZN   174.88 (-0.06%)
TSLA   199.85 (+4.10%)
NVDA   797.91 (+1.24%)
NIO   5.58 (+3.33%)
AMD   176.57 (+0.03%)
BABA   76.15 (+0.25%)
T   16.66 (-0.83%)
F   12.13 (-0.08%)
MU   90.77 (+5.55%)
CGC   3.46 (+2.98%)
GE   154.64 (+0.85%)
DIS   108.63 (+0.83%)
AMC   4.48 (+0.90%)
PFE   27.23 (-1.91%)
PYPL   59.79 (+1.06%)
XOM   104.43 (+0.57%)

Avenue Therapeutics (ATXI) Short Interest Ratio & Short Volume

$0.14
+0.00 (+3.57%)
(As of 11:32 AM ET)

Avenue Therapeutics Short Interest Data

Current Short Volume
677,300 shares
Previous Short Volume
1,110,000 shares
Change Vs. Previous Month
-38.98%
Dollar Volume Sold Short
$100,240.40
Short Interest Ratio / Days to Cover
0.1
Last Record Date
January 31, 2024
Outstanding Shares
13,250,000 shares
Percentage of Shares Shorted
5.11%
Today's Trading Volume
488,178 shares
Average Trading Volume
7,615,392 shares
Today's Volume Vs. Average
6%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avenue Therapeutics ?

Sign up to receive the latest short interest report for Avenue Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATXI Short Interest Over Time

ATXI Days to Cover Over Time

ATXI Percentage of Float Shorted Over Time


Avenue Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024677,300 shares $100,240.40 -39.0%N/A0.1 $0.15
1/15/20241,110,000 shares $193,140.00 +378.9%N/A0.2 $0.17
12/31/2023231,800 shares $37,319.80 +1.2%3.1%0 $0.16
12/15/2023229,100 shares $33,906.80 -65.6%2.4%0.1 $0.15
11/30/2023665,300 shares $141,043.60 +329.8%9.2%0.4 $0.21
11/15/2023154,800 shares $28,730.88 -69.9%1.6%0.8 $0.19
10/31/2023513,700 shares $120,719.50 +39.0%7.7%3.3 $0.24
10/15/2023369,700 shares $221,746.06 +73.2%5.6%5.7 $0.60
9/30/2023213,400 shares $150,873.80 +699.3%3.3%2.9 $0.71
9/15/202326,700 shares $22,134.30 +184.0%0.5%0.4 $0.83
8/31/20239,400 shares $7,294.40 -69.9%0.1%0.2 $0.78
8/15/202331,200 shares $31,200.00 -47.7%0.5%0.5 $1.00
7/31/202359,600 shares $62,580.00 -12.2%0.9%0.8 $1.05
7/15/202367,900 shares $81,276.30 -45.9%1.1%0.7 $1.20
6/30/2023125,400 shares $144,210.00 -4.7%2.0%0.6 $1.15
6/15/2023131,600 shares $152,656.00 -32.7%2.1%0.5 $1.16
5/31/2023195,500 shares $211,140.00 -35.0%3.3%0.5 $1.08
5/15/2023300,700 shares $321,749.00 -16.3%5.1%0.6 $1.07
4/30/2023359,100 shares $341,109.09 +49.8%5.2%0.7 $0.95
4/15/2023239,700 shares $261,273.00 -16.6%3.9%0.4 $1.09
3/31/2023287,300 shares $334,704.50 -36.7%4.8%0.3 $1.17
3/15/2023453,900 shares $531,063.00 +208.8%7.5%0.5 $1.17
2/28/2023147,000 shares $163,170.00 -10.7%2.4%0.2 $1.11
2/15/2023164,600 shares $204,104.00 -42.8%2.7%0.2 $1.24
1/31/2023287,500 shares $396,750.00 +229.0%6.6%0.3 $1.38
1/15/202387,400 shares $106,628.00 -16.4%2.1%0.1 $1.22
12/30/2022104,500 shares $121,220.00 -17.1%2.4%0 $1.16
12/15/2022126,100 shares $156,364.00 -8.5%2.8%0 $1.24
11/30/2022137,800 shares $184,652.00 +66.2%3.1%0 $1.34
11/15/202282,900 shares $137,614.00 -61.0%1.9%0 $1.66
10/31/2022212,600 shares $508,114.00 +1,463.2%5.6%0.1 $2.39
10/15/202213,600 shares $45,288.00 -97.4%0.4%0 $3.33
9/30/2022524,700 shares $5.29 million +1,836.2%69.5%0.2 $10.08
9/15/202227,100 shares $108,535.50 -82.1%N/A0.1 $4.01
8/31/2022151,200 shares $36,408.96 +91.4%1.3%0.5 $0.24
8/15/202279,000 shares $23,091.70 +28.5%0.7%0.3 $0.29
7/31/202261,500 shares $15,768.60 +104.3%0.5%0.2 $0.26
7/15/202230,100 shares $8,033.69 -61.2%0.3%0.1 $0.27
6/30/202277,600 shares $20,897.68 -17.5%0.7%0.2 $0.27
6/15/202294,000 shares $25,192.00 +50.9%0.8%0.3 $0.27













ATXI Short Interest - Frequently Asked Questions

What is Avenue Therapeutics' current short interest?

Short interest is the volume of Avenue Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 677,300 shares of ATXI short. Learn More on Avenue Therapeutics' current short interest.

Is Avenue Therapeutics' short interest increasing or decreasing?

Avenue Therapeutics saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 677,300 shares, a drop of 39.0% from the previous total of 1,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Avenue Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avenue Therapeutics: Allarity Therapeutics, Inc. (13.17%), Neptune Wellness Solutions Inc (0.15%), 60 Degrees Pharmaceuticals, Inc. (15.72%), Biodexa Pharmaceuticals Plc (3.64%), Phio Pharmaceuticals Corp. (0.56%), CNS Pharmaceuticals, Inc. (10.17%), Biofrontera Inc. (2.99%), CohBar, Inc. (0.59%), Salarius Pharmaceuticals, Inc. (0.23%), Adial Pharmaceuticals, Inc. (1.51%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Avenue Therapeutics stock?

Short selling ATXI is an investing strategy that aims to generate trading profit from Avenue Therapeutics as its price is falling. ATXI shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avenue Therapeutics?

A short squeeze for Avenue Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATXI, which in turn drives the price of the stock up even further.

How often is Avenue Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATXI, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ATXI) was last updated on 2/26/2024 by MarketBeat.com Staff